Fulcrum Therapeutics (FULC) Return on Assets (2019 - 2026)
Fulcrum Therapeutics (FULC) reported Return on Assets of 0.0% for Q1 2026, little changed year-over-year from 0.0% in Q1 2025, and up 17.15% quarter-over-quarter from 0.0% in Q4 2025.
Fulcrum Therapeutics (FULC) Return on Assets (2019 - 2026) Analysis & Trends
Fulcrum Therapeutics (FULC) has 8 years of Return on Assets data on file, last reported at 0.0% in Q1 2026.
- Return on Assets for Q1 2026 came in at 0.0%, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY), and the FY2025 annual result was 0.0%, changed 0.0% from the prior year.
- Return on Assets climbed to 0.0% in Q1 2026 per FULC's latest filing, from 0.0% in the prior quarter.
- Over five years, Return on Assets peaked at 0.0% in Q1 2025 and troughed at 0.01% in Q2 2022.
- A 5-year average of 0.0% and a median of 0.0% in 2025 frame the typical range for Return on Assets.
- On a YoY basis, Return on Assets climbed as much as 0 bps in 2022 and fell as far as 0 bps in 2022.
- A 5-year view of Return on Assets shows it stood at 0.0% in 2022, then advanced by 22 bps to 0.0% in 2023, then jumped by 90 bps to 0.0% in 2024, then tumbled by 615 bps to 0.0% in 2025, then rose by 17 bps to 0.0% in 2026.
- Business Quant data shows FULC's Return on Assets at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | -0.80% |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -0.01% |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 0.00% |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -0.01% |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 0.00% |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 0.00% |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 0.00% |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -0.01% |
| 10 | Fulcrum Therapeutics | 267.90 Mn | 267.90 Mn | - | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | -0.01% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |
| Jun 30, 2021 | 0.00% |